13.09.2019 • News

Ashland Closes Sale of Composites to Ineos

Ashland Closes Sale of Composites to Ineos (c) Evonik
Ashland Closes Sale of Composites to Ineos (c) Evonik

Ashland Global Holdings has completed the previously announced sale of its composites business (amended to exclude the maleic business) and its butanediol (BDO) manufacturing facility in Marl, Germany, to Ineos for just over at $1 billion.

The holding for the US chemical group said net proceeds from the sale totaled around $930 million. At the same time, it has retired or expects to retire more than $900 million in debt.

Selling the businesses “allows Ashland to focus on its vision of becoming the premier specialty chemicals company," said chairman and CEO Bill Wulfsohn. He said the transaction, combined with the company’s cost reduction program, “will help better position Ashland to deliver sustained earnings growth and significant value for shareholders”.

Ashland’s maleic assets comprise one facility in West Virginia, which generates annual revenue of about $75 million. The company said it will retain its ownership initially, but – in exchange for the unchanged price of the original deal – would sell the maleic assets following the deal’s closing. All proceeds, less reasonable costs incurred by Ashland, will go to Ineos.

Ashland is retaining its BDO plant in Lima, Ohio, USA.

 

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.